Exciting Investment Opportunity in the Junior Resources and Disruptive Technologies Sectors
ThreeD Capital Inc. Acquires Shares in Sariel Diagnostics Corp.
TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that it has closed its previously announced Securities Purchase Agreement (the “Agreement”) with Sariel Diagnostics Corp. (“Sariel”), a privately held corporation existing under the laws of the Province of British Columbia. In accordance with the Agreement, ThreeD has acquired 3,200,000 common shares of Sariel at a price of $0.05 per share. In consideration, ThreeD has issued an aggregate of 200,000 common shares of the Company at a deemed price of $0.80 per common share. No commission or finders’ fees were paid in connection with the Agreement.
ThreeD Capital Inc.’s recent acquisition of shares in Sariel Diagnostics Corp. represents an exciting investment opportunity in the junior resources and disruptive technologies sectors. The Company’s strategic focus on opportunistic investments in these high-growth industries positions it well for potential long-term success.
Sariel Diagnostics Corp., a privately held corporation based in British Columbia, offers innovative solutions in the diagnostics sector. With ThreeD’s acquisition of 3,200,000 common shares of Sariel at a favorable price of $0.05 per share, the Company demonstrates its confidence in the potential growth of Sariel’s business.
In exchange for the shares in Sariel, ThreeD has issued 200,000 common shares of the Company at a deemed price of $0.80 per common share. This exchange showcases ThreeD’s commitment to strategic partnerships and further diversification of its investment portfolio.
Impact on Me
As an individual investor, ThreeD Capital Inc.’s acquisition of shares in Sariel Diagnostics Corp. presents an intriguing opportunity to potentially benefit from the growth and success of innovative companies in the junior resources and disruptive technologies sectors. By aligning with a venture capital firm with a strong track record and expertise in these industries, investors may have the chance to participate in exciting ventures with promising growth prospects.
Impact on the World
ThreeD Capital Inc.’s investment in Sariel Diagnostics Corp. reflects a broader trend of venture capital firms actively supporting companies in the junior resources and disruptive technologies sectors. This strategic alliance has the potential to drive innovation, fuel economic growth, and create new opportunities in these dynamic industries. By fostering collaboration and investment in groundbreaking technologies, ThreeD and Sariel are contributing to the advancement of global innovation and progress.
Conclusion
Overall, ThreeD Capital Inc.’s acquisition of shares in Sariel Diagnostics Corp. marks an exciting development in the venture capital landscape, particularly in the junior resources and disruptive technologies sectors. This strategic partnership has the potential to generate positive outcomes for investors, industry stakeholders, and the global economy at large. As innovation continues to drive growth and transformation in various sectors, collaborations like the one between ThreeD and Sariel exemplify the importance of forward-thinking investment strategies and entrepreneurial partnerships.
